Drug
Contrast
Contrast is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(20%)
Results Posted
33%(1 trials)
Phase Distribution
Ph phase_2
1
20%
Ph not_applicable
2
40%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(3)
Other(1)
Detailed Status
Completed3
Recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
recruiting120%
completed360%
unknown120%
Recent Activity
1 active trials
Showing 5 of 5
recruitingnot_applicable
Coronary Atherosclerosis T1-Weighted Characterization (CATCH)
NCT03504956
completedphase_2
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
NCT01334918
unknown
Whole-Heart Myocardial Blood Flow Quantification Using MRI
NCT03064295
completednot_applicable
DYNA EMBOLIZATION - Pilot Study of IV Dyna CT and CBV Imaging Techniques
NCT03528200
completed
Aging Biomakers and ConTrast Induced Nephropathy (ACTIN) Trial
NCT02650336
Clinical Trials (5)
Showing 5 of 5 trials
NCT03504956Not Applicable
Coronary Atherosclerosis T1-Weighted Characterization (CATCH)
NCT01334918Phase 2
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
NCT03064295
Whole-Heart Myocardial Blood Flow Quantification Using MRI
NCT03528200Not Applicable
DYNA EMBOLIZATION - Pilot Study of IV Dyna CT and CBV Imaging Techniques
NCT02650336
Aging Biomakers and ConTrast Induced Nephropathy (ACTIN) Trial
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5